The Biden Administration on Thursday announced it is setting new policy that will allow it to seize patents for medicines developed with government funding if it believes their prices are too high.

The policy creates a roadmap for the government’s so-called march-in rights, which have never been used before. They would allow the government to grant additional licenses to third parties for products developed using federal funds if the original patent holder does not make them available to the public on reasonable terms.

Under the draft roadmap, seen by Reuters, the government will consider factors including whether only a narrow set of patients can afford the drug, and whether drugmakers are exploiting a health or safety issue by hiking prices.

“We’ll make it clear that when drug companies won’t sell taxpayer funded drugs at reasonable prices, we will be prepared to allow other companies to provide those drugs for less,” White House adviser Lael Brainard said on a press call.

  • LifeInMultipleChoice@lemmy.world
    link
    fedilink
    English
    arrow-up
    0
    ·
    9 months ago

    Being that he focused on Insulin being brought down to no more than $35 a month for medicaid, it is a high likelyhood that is one of the first drugs on the list.

    • !deleted120991@kbin.social
      link
      fedilink
      arrow-up
      0
      ·
      9 months ago

      Should be free. It’s ridiculous anyone should have to pay for it at all.

      Go find a hedge fund and tax the fuck out of just that one and you’ll probably get enough money to offset costs for the entire year for all Americans.

      Little bit of hyperbole in there but stand by my point.

      • Aniki 🌱🌿@lemm.ee
        link
        fedilink
        English
        arrow-up
        0
        arrow-down
        1
        ·
        edit-2
        9 months ago

        PREACH. We’re not a poor nation. We deserve universal, national healthcare. Fuck both parties, the R for making everything worse, and the Ds for peace-meal, ineffective horseshit, and a blowjob to the insurance industry.